Kensey Nash Corporation 

(Public, NASDAQ:KNSY)   Watch this stock   
Find more results for KNSY
Jan 28, 2010
Q2 2010 Earnings Conference Call - Webcast
Jan 28, 2010
Q2 2010 Earnings Release
More events from AOL Finance »    

Key stats and ratios

Q4 (Dec '09) 2009
Net profit margin 19.19% 24.46%
Operating margin 30.35% 37.20%
EBITD margin - 45.11%
Return on average assets 8.36% 12.04%
Return on average equity 11.42% 16.88%
Employees 302 -

Address

735 Pennsylvania Drive
Exton, PA 19341
United States - Map
+1-484-7132100 (Phone)
+1-484-7132900 (Fax)

Website links

External links

Analyst Estimates - MarketWatch
SEC Filings - EDGAR Online
Major Holders - MSN Money
Options - Morningstar
Research Reports - Yahoo Finance
Annual Report (PDF) - AnnualReports.com

Kensey Nash Corporation discussions

  View all discussions »

Description

Kensey Nash Corporation is a medical device company providing solutions and technologies for a range of medical procedures. The Company provides a range of products into multiple medical markets, primarily in the cardiology, orthopaedic, sports medicine, spine, endovascular and general surgery markets. It sells all its products through strategic partners. It has invented the Angio-Seal Vascular Closure Device (Angio-Seal), which is licensed to St. Jude Medical, Inc. (St. Jude Medical). Kensey Nash Corporation manufactures resorbable components for the Angio-Seal device. During the fiscal year ended June 30, 2009 (fiscal 2009), the Company manufactured and sold over four million resorbable product units representing approximately 220 commercialized products to strategic partners and customers.

Officers and directors

Joseph W. Kaufmann
President, Chief Executive Officer, Secretary, Director
Age: 57
Bio & Compensation - Reuters
Michael Celano
Chief Financial Officer
Age: 51
Bio & Compensation - Reuters
Douglas G. Evans
Chief Operating Officer, Assistant Secretary, Director
Age: 45
Bio & Compensation - Reuters
James Rauth
Vice President - Operations
Age: 45
Bio & Compensation - Reuters
John E. Nash
Vice President - New Technology
Age: 74
Bio & Compensation - Reuters
Todd M. DeWitt Ph.D.
Vice President - Biomaterials
Age: 55
Bio & Compensation - Reuters
Walter R. Maupay Jr.
Non-Executive Chairman of the Board
Age: 70
Bio & Compensation - Reuters
Robert J. Bobb
Director
Age: 61
Bio & Compensation - Reuters
Harold N. Chefitz
Director
Age: 73
Bio & Compensation - Reuters
C. McCollister Evarts M.D.
Director
Age: 78
Bio & Compensation - Reuters